NCT05387369View on ClinicalTrials.gov

A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19

RecruitingOBSERVATIONAL
Enrollment

2,000

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

March 30, 2023

Study Completion Date

March 30, 2027

Conditions
COVID-19
Interventions
DRUG

Paxlovid

The study is a real-world study. According to the actual medical history of patients, the usage of paxlovid will be collected.

Trial Locations (1)

Unknown

RECRUITING

Huashan Hospital Affiliated to Fudan University, Shanghai

All Listed Sponsors
lead

Huashan Hospital

OTHER